Bio-Rad Laboratories Class B
BIO.B
9 hedge funds and large institutions have $1.9M invested in Bio-Rad Laboratories Class B in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
13% more funds holding
Funds holding: 8 → 9 (+1)
0% more ownership
Funds ownership: 0.1% → 0.11% (+0%)
15% less capital invested
Capital invested by funds: $2.22M → $1.9M (-$322K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
+$164K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$14.3K |
| 3 |
PB
Pinnacle Bancorp
Beatrice,
Nebraska
|
+$1.23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$81.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $777K | +$164K | +402 | +28% |
|
|
2
Renaissance Technologies
New York
| $384K | -$81.7K | -200 | -10% |
|
|
BSW
3
Buckingham Strategic Wealth
Clayton,
Missouri
| $313K | – | – | – |
|
4
Morgan Stanley
New York
| $298K | – | – | – |
|
|
WT
5
Whittier Trust
South Pasadena,
California
| $64.7K | – | – | – |
|
6
Wells Fargo
San Francisco,
California
| $22.7K | – | – | – |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $21K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $14.8K | +$14.3K | +35 | +3,500% |
|
|
PB
9
Pinnacle Bancorp
Beatrice,
Nebraska
| $1K | +$1.23K | +3 | New |
|
BIO.B Hedge Fund Activity: Q4 2022 in Review
9 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q4 2022, worth a combined $1.9M — down 15% from $2.22M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIO.B positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was CSS LLC, adding an estimated $164K. The largest seller was Renaissance Technologies, cutting an estimated $81.7K.
- 9 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q4 2022, up from 8 in Q3 2022.
- Funds reported $1.9M of Bio-Rad Laboratories Class B stock for Q4 2022, down 15% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q4 2022 and 0 closed out, a net change of +1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q4 2022 was CSS LLC, an estimated $164K added.
- The largest Bio-Rad Laboratories Class B seller in Q4 2022 was Renaissance Technologies, an estimated $81.7K sold.
Based on aggregated 13F filings for Q4 2022.